Shares of PepsiCo, Inc. (NASDAQ: PEP) were down over 2% on Tuesday, despite the company delivering better-than-expected results for the first quarter of 2024. The top and bottom line numbers grew year-over-year and surpassed projections, despite certain challenges in the Quaker Foods segment and tough year-ago comparisons. Here are the key takeaways from the report:
Results beat estimates
PepsiCo reported net revenue of $18.2 billion for Q1 2024, which rose 2.3% year-over-year and beat expectations of $18.1 billion. Organic revenue growth was 2.7%. GAAP net income increased 6% to $2 billion, or $1.48 per share. Core EPS grew 7% to $1.61, beating projections of $1.52.
Segment performance
In Q1, PepsiCo recorded revenue growth across all its segments, both on a reported and organic basis, barring Quaker Foods North America, which saw a double-digit decline, mainly due to product recalls.
The Frito-Lay North America segment saw organic revenue growth of 2%, helped by brands such as Cheetos and Doritos, which delivered mid-single-digit revenue growth. Brands that target specialty snacking occasions or positive choices, such as Miss Vickie’s and BARE, witnessed double-digit revenue growth. The company also recorded gains from brands such as SunChips, PopCorners, and Stacy’s during the quarter.
Quaker Foods North America saw organic revenues fall 24% due to product recalls and soft category growth. In its report, PepsiCo said it plans to close the manufacturing facility involved in the recalls and that it has resumed limited production on certain products affected by the recalls through other facilities. The company expects production to pick up in the coming months and the financial impacts of these recalls to moderate as the year moves on.
PepsiCo Beverages North America saw organic revenue growth of 1%, helped by gains in Pepsi, Mountain Dew, Propel, bubbly, and Gatorade. PepsiCo’s International business delivered organic revenue growth of 9% in the quarter.
Outlook
Looking ahead, PepsiCo expects its international businesses to perform well on the back of strong category growth in developing and emerging markets. It also expects a gradual improvement in its North America businesses as comparisons ease and the impact of product recalls moderate.
PepsiCo continues to expect organic revenue growth of at least 4% and core constant currency EPS growth of at least 8% for the full year of 2024. Core EPS is expected to be at least $8.15, representing a growth of 7% from 2023.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on